檢索結果 - Konrad Talbot
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer’s and Parkinson’s diseases 由 Elizabeth M. Rhea, Alice Babin, P. C. Thomas, Mohamed Omer, Riley Weaver, Kim M. Hansen, William A. Banks, Konrad Talbot
出版 2023Artigo -
9
-
10
Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression 由 Jinsong Tang, Romain Legros, Natalia Louneva, L. Yeh, Joshua W. Cohen, Chang-Gyu Hahn, Derek J. Blake, S. E. Arnold, Konrad Talbot
出版 2009Artigo -
11
-
12
Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia 由 Gregory C. Carlson, Konrad Talbot, Tobias Halene, Michael J. Gandal, Hala Kazi, Laura Schlosser, Quan Phung, Raquel E. Gur, Steven E. Arnold, Steven J. Siegel
出版 2011Artigo -
13
Association of Anxiety and Depression With Microtubule-Associated Protein 2– and Synaptopodin-Immunolabeled Dendrite and Spine Densities in Hippocampal CA3 of Older Humans 由 Ainie Soetanto, R. J. Wilson, Konrad Talbot, Ashley Un, Julie A. Schneider, Mark Sobiesk, Jeremiah Kelly, Sue E. Leurgans, David A. Bennett, Steven E. Arnold
出版 2010Artigo -
14
-
15
The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse 由 Jennifer Larimore, Karine Tornieri, Pearl V. Ryder, Avanti Gokhale, Stephanie A. Zlatic, Branch Craige, Joshua D. Lee, Konrad Talbot, Jean‐François Paré, Yoland Smith, Victor Faúndez
出版 2011Artigo -
16
-
17
Age-dependent synuclein pathology following traumatic brain injury in mice 由 Kunihiro Uryu, Benoit I. Giasson, Luca Longhi, Daniel Martínez, Ian Murray, V. Conte, Michio Nakamura, Kathryn E. Saatman, Konrad Talbot, Takashi Horiguchi, Tracy K. McIntosh, VIRGINIA M.‐Y. LEE, John Q. Trojanowski
出版 2003Artigo -
18
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia 由 Konrad Talbot, Wess L. Eidem, Caroline L. Tinsley, Matthew A. Benson, Edward W. Thompson, Rachel J. Smith, Chang-Gyu Hahn, Steven J. Siegel, John Q. Trojanowski, Raquel E. Gur, Derek J. Blake, Steven E. Arnold
出版 2004Artigo -
19
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia 由 Konrad Talbot, Wess L. Eidem, Caroline L. Tinsley, Matthew A. Benson, Edward W. Thompson, Rachel J. Smith, Chang-Gyu Hahn, Steven J. Siegel, John Q. Trojanowski, Raquel E. Gur, Derek J. Blake, Steven E. Arnold
出版 2004Artigo -
20
Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline 由 Konrad Talbot, Hoau-Yan Wang, Hala Kazi, Liying Han, Kalindi Bakshi, Andres Stucky, Robert L. Fuino, Krista R. Kawaguchi, Andrew Samoyedny, Robert S. Wilson, Zoe Arvanitakis, Julie A. Schneider, Bryan A. Wolf, David A. Bennett, John Q. Trojanowski, Steven E. Arnold
出版 2012Artigo
相關主題
Biology
Neuroscience
Genetics
Medicine
Psychology
Gene
Psychiatry
Receptor
Internal medicine
Endocrinology
Hippocampal formation
Schizophrenia (object-oriented programming)
Disease
Cognition
Dentate gyrus
Diabetes mellitus
Hippocampus
Biochemistry
Cell biology
Gene expression
Glutamate receptor
Insulin
Insulin resistance
Type 2 diabetes
Cognitive decline
Computational biology
Dementia
Expression quantitative trait loci
Genotype
Glutamatergic